{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:12:24Z","timestamp":1777669944276,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier","isbn-type":[{"value":"9780128114322","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/b978-0-12-809633-8.20665-1","type":"book-chapter","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T04:25:53Z","timestamp":1524457553000},"page":"1093-1098","source":"Crossref","is-referenced-by-count":5,"title":["Preclinical: Drug Target Identification and Validation in Human"],"prefix":"10.1016","author":[{"given":"Meena K.","family":"Sakharkar","sequence":"first","affiliation":[]},{"given":"Karthic","family":"Rajamanickam","sequence":"additional","affiliation":[]},{"given":"Chidambaram S.","family":"Babu","sequence":"additional","affiliation":[]},{"given":"Jitender","family":"Madan","sequence":"additional","affiliation":[]},{"given":"Ramesh","family":"Chandra","sequence":"additional","affiliation":[]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1742-7843.2004.pto950402.x","article-title":"Genetically engineered animals in drug discovery and development: A maturing resource for toxicological research","volume":"95","author":"Bolon","year":"2004","journal-title":"Basic and Clinical Pharmacology and Toxicology"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/30.1.412","article-title":"TTD: Therapeutic target database","volume":"30","author":"Chen","year":"2002","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: Databases, web servers and computational models","volume":"17","author":"Chen","year":"2016","journal-title":"Briefings in Bioinformatics"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib5","first-page":"374","article-title":"Cheminformatics analysis of organic substituents: Identification of the most common substituents, calculation of substituent properties, and automatic identification of drug-like bioisosteric groups","volume":"43","author":"Ertl","year":"2003","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Science Translational Medicine"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2217\/bmm.09.71","article-title":"The application of biomarkers in clinical trials for motor neuron disease","volume":"4","author":"Ganesalingam","year":"2010","journal-title":"Biomarkers in Medicine"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib8","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1073\/pnas.1204524109","article-title":"Identifying mechanism-of-action targets for drugs and probes","volume":"109","author":"Gregori-PuigJane","year":"2012","journal-title":"Proceedings of National Academy of Science"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S1359-6446(05)03624-X","article-title":"Predicting protein druggability","volume":"10","author":"Hajduk","year":"2005","journal-title":"Drug Discovery Today"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib11","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/1078-0432.CCR-08-2054","article-title":"Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model","volume":"15","author":"Kadoch","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib12","doi-asserted-by":"crossref","unstructured":"Kangueane, P., Sowmya, G., Anupriya, S., et al., 2015. Short peptide vaccine design and development: Promises and challenges. In: Global Virology I-Identifying and Investigating Viral Diseases. Springer.","DOI":"10.1007\/978-1-4939-2410-3_1"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib13","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.2007.00548.x","article-title":"Drugs and their molecular targets: An updated overview","volume":"22","author":"Landry","year":"2008","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib15","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1186\/s12864-016-3260-7","article-title":"DeSigN: Connecting gene expression with therapeutics for drug repurposing and development","volume":"18","author":"Lee","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib16","doi-asserted-by":"crossref","first-page":"bau124","DOI":"10.1093\/database\/bau124","article-title":"DCDB 2.0: A major update of the drug combination database","volume":"2014","author":"Liu","year":"2014","journal-title":"Database, Oxford"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib17","first-page":"757","article-title":"Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery","volume":"12","author":"Nowotka","year":"2017","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib18","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S1359-6446(05)03621-4","article-title":"Beyond annotation transfer by homology: Novel protein-function prediction methods to assist drug discovery","volume":"10","author":"Ofran","year":"2005","journal-title":"Drug Discovery Today"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","article-title":"How many drug targets are there?","volume":"5","author":"Overington","year":"2006","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib20","first-page":"100","article-title":"A comparative study of metabolic network topology between a pathogenic and a non-pathogenic bacterium for potential drug target identification","volume":"2009","author":"Perumal","year":"2009","journal-title":"Summit on Translational Bioinformatics"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00894-008-0353-5","article-title":"Meta-basic estimates the size of druggable human genome","volume":"15","author":"Plewczynski","year":"2009","journal-title":"Journal of Molecular Modeling"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib22","doi-asserted-by":"crossref","first-page":"D1118","DOI":"10.1093\/nar\/gkt1129","article-title":"Therapeutic target database update 2014: A resource for targeted therapeutics","volume":"42","author":"Qin","year":"2014","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/157016307781115494","article-title":"Targetability of human disease genes","volume":"4","author":"Sakharkar","year":"2007","journal-title":"Current Drug Discovery Technology"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib24","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biocel.2007.02.018","article-title":"Druggability of human disease genes","volume":"39","author":"Sakharkar","year":"2007","journal-title":"International Journal of Biochemistry and Cell Biology"},{"issue":"Suppl. 5","key":"10.1016\/B978-0-12-809633-8.20665-1_bib25","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1471-2164-14-S5-S6","article-title":"Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer","volume":"14","author":"Shashni","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib26","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15 \u2013 Ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-62703-435-7_20","article-title":"PharmGKB: The pharmacogenomics knowledge base","volume":"1015","author":"Thorn","year":"2013","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/biomedicines4040027","article-title":"Complementary approaches to existing target based drug discovery for identifying novel drug targets","volume":"4","author":"Vasaikar","year":"2016","journal-title":"Biomedicines"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib29","doi-asserted-by":"crossref","first-page":"293ps15","DOI":"10.1126\/scitranslmed.aab1201","article-title":"Developing predictive assays: The phenotypic screening \u201crule of 3\u201d","volume":"7","author":"Vincent","year":"2015","journal-title":"Science Translational Medicine"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib30","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018","author":"Wishart","year":"2017","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib31","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: A knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/B978-0-12-809633-8.20665-1_bib32","first-page":"127","article-title":"MHC-Peptide binding prediction for epitope based vaccine design","volume":"1","author":"Zhao","year":"2007","journal-title":"International Journal of Integrative Biology"}],"container-title":["Encyclopedia of Bioinformatics and Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128096338206651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128096338206651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:08:46Z","timestamp":1548119326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128096338206651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128114322"],"references-count":31,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-809633-8.20665-1","relation":{},"subject":[],"published":{"date-parts":[[2019]]}}}